🇺🇸 FDA
Pipeline program

droxidopa

199/14180

Unknown small_molecule completed

Quick answer

droxidopa for Shy-Drager Syndrome is a Unknown program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Shy-Drager Syndrome
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials